Effects of the administration of captopril, metoprolol and of the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction

International Journal of Cardiology

Volumn 46, Issue 2, 1994, Pages 107-112

  Pasquale, Pietro di ^a   Paterna, Salvatore ^b   Bucca, Vincenzo ^a   Maringhini, Giorgio ^a   Magatti, Marika ^c  

^a Ospedale GF Ingrassia   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

Author keywords

Beta blockers; Captopril; Infarction; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; METOPROLOL; NITRATE; PLACEBO; UROKINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

AGED; CAPTOPRIL; CHEMOTHERAPY, ADJUVANT; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE VOLUME; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0028106923     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(94)90030-2     Document Type: Article

References (24)

1. TIMI Study group comparison on invasive and conservative strategies following tissue plasminogen activator in acute myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI II) trial
2. The MIAMI trial research group Metoprolol in Acute Myocardial Infarction (MIAMI) a randomized placebo-controlled international trial
3. ISIS 1 (first International Study of Infarct Survival) colaborative grouprandomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction ISIS 1
4. ISIS-2 collaborative grouprandomized trial of iv streptokinase oral aspirin both or neither among 17 187 cases of suspected acute infarction
5. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction
6. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial (on behalf of the SAVE investigators)
7. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure The acute infarction ramipril efficacy (AIRE) study investigators
8. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
9. Protection of the myocardium against postischemic reperfusion damage: possible role of angiotensin-converting enzyme inhibitors
10. Captopril before reperfusion in acute myocardial infarction: the CAPTIN experience [abstract]
11. A randomised placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction
12. Does captopril treatment, before thrombolysis in acute myocardial infarction, attenuate reperfusion damage? Short term and long term effects
13. Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction. Effects of beta-adrenergic blockade
14. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy
15. Immediate versus differed beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI II B) study
16. Circulating endothelin in acute ischaemic syndromes
17. Catecholamines in myocardial ischemia
18. Reduced beta-adrenergic receptor sequestration on human mononuclear leukocytes exposed to hypoxia
19. Effect of captopril on lymphocytic beta-adrenergic receptors in normal and hypoxic conditions
20. Interaction of angiotensin-converting enzyme inhibition with the function of the sympathetic nervous system
21. Captopril an ACE-inhibitor, for optimizing reperfusion after acute myocardial infarction
22. Coronary vasodilation by sulphydryl containing converting enzyme inhibitors is affected by the precusor of endothelium derived relaxing factor [abstract P]
23. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
24. Direct scavenging of free radicals by captopril, an angiotensin enzyme inhibitor